P-162 * Interim Results of IMMU-132 (Sacituzumab...

Annals of Oncology 2015 / 06 Vol. 26; Iss. suppl 4

P-162 * Interim Results of IMMU-132 (Sacituzumab Govitecan), an Anti-Trop-2 Antibody-Drug Conjugate (ADC), in Patients (pts) with Metastatic Gastrointestinal (GI) Cancers

Ocean, A., Starodub, A., Messersmith, W., Picozzi, V., Guarino, M., Thomas, S., Bardia, A., Shah, M., Govindan, S., Maliakal, P., Wegener, W., Sharkey, R., Wilhelm, F., Goldenberg, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.162
Date:
June, 2015
File:
PDF, 60 KB
english, 2015
Conversion to is in progress
Conversion to is failed